SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000926617-22-000030
Filing Date
2022-05-11
Accepted
2022-05-11 16:00:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A awh-20220511xdefa14a.htm DEFA14A 66440
2 GRAPHIC awh-20220511xdefa14ag001.jpg GRAPHIC 4677
3 GRAPHIC awh-20220511xdefa14ag002.jpg GRAPHIC 84385
4 GRAPHIC awh-20220511xdefa14ag003.jpg GRAPHIC 68162
  Complete submission text file 0000926617-22-000030.txt   284763
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34810 | Film No.: 22913580
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences